Supporting Analytical Tech Transfer Under Real-World Constraints to Maintain Method Identity, Reduce Drift & Avoid Rebuilding Assays Mid-Development

• Explore how analytical developers can protect method intent when transferring into a platform environment
• Diagnose performance changes post-transfer and deciding between retraining, re-optimisation, or full method redevelopment
• How to interpret shifts in potency signal, vector titre, or impurity profiles across sites

Speakers:

Simon Briggs

Director - Advanced Analytics

Orchard Therapeutics